# COVID-19 and Multiple Sclerosis Disease Modifying Therapies

> **NCT04863586** · — · UNKNOWN · sponsor: **Nottingham University Hospitals NHS Trust** · enrollment: 14240 (estimated)

## Conditions studied

- Covid19
- Multiple Sclerosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04863586
- **Lead sponsor:** Nottingham University Hospitals NHS Trust
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2021-10-31
- **Final completion:** 2022-05-31
- **Target enrollment:** 14240 (ESTIMATED)
- **Last updated:** 2021-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04863586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04863586, "COVID-19 and Multiple Sclerosis Disease Modifying Therapies". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04863586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*